RxAnte
RxAnte provides patented predictive analytics and clinical workflow technology to U.S. health plans for improving medication adherence, pharmacy quality, and total cost of care. Its RxEffect tool, RxAnte Score models, and Mosaic Pharmacy Service subsidiary serve Medicare Advantage, Medicaid, and commercial plans managing 34M+ lives.
- Company typePrivate
- Founded2011
- HeadquartersPortland, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What RxAnte does
RxAnte is a Portland, Maine-based healthcare technology company founded in 2011 that builds predictive analytics and clinical workflow software to improve medication prescribing and adherence, primarily for U.S. health plans serving Medicare Advantage, Medicaid, and Commercial populations. The platform combines three patented technology layers: RxAnte Core Analytics/RxAnte Score (member-level adherence and unsafe-use risk scoring protected by U.S. Patent 11,244,029), Value of Future Adherence predictive models (protected by four additional patents including 10,318,897 and 11,887,027), and RxEffect, a clinical workflow solution for pharmacists, care managers, and community-based providers (protected by four patents including 10,108,975 and 12,327,262). The company operates its technology-enabled pharmacy care management subsidiary, Mosaic Pharmacy Service, as a value-based pharmacy service for medically complex and vulnerable Medicare beneficiaries, managing over 34 million lives as of 2026.
RxAnte generates revenue through subscription analytics services (population-level reporting and member-level predictions delivered on a recurring basis), value-based pharmacy services via Mosaic, performance-based contracts that use real-world evidence to support value-based agreements between health plans and pharma manufacturers, and clinical intervention programs. Pricing is enterprise-negotiated and not publicly disclosed. Go-to-market is direct enterprise field sales targeting health plan C-suite, pharmacy directors, and quality executives, with a curated network of patient engagement vendors and provider network partnerships (RxEffect) extending reach to mid-market providers.
The company has accumulated roughly $44.6 million+ in disclosed institutional capital across rounds from Aberdare Ventures, West Health Investment Fund, UPMC Enterprises, Trinity Capital, and Primus Capital, with Primus Capital's January 2026 strategic growth investment the most recent signal of institutional confidence. Notable commercial partners include UPMC Health Plan (customer since 2013, equity partner since 2016), Geisinger Health Plan, AvMed, Horizon Healthcare Services, EnvisionInsurance, WellCare Health Plans, and Aetna. The company is HITRUST CSF Certified and SOC 2 Type II certified, both prerequisites for handling protected health information at health-plan scale.
RxAnte firmographics
Firmographics- Name
- RxAnte
- Legal name
- RxAnte, Inc.
- Website
- https://rxante.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- RxAnte provides patented predictive analytics and clinical workflow technology to U.S. health plans for improving medication adherence, pharmacy quality, and total cost of care. Its RxEffect tool, RxAnte Score models, and Mosaic Pharmacy Service subsidiary serve Medicare Advantage, Medicaid, and commercial plans managing 34M+ lives.
- Ownership category
- akta.pro rank
RxAnte industry classification
Industry- Product category
- Pharmacy Care Management Analytics
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Pharmacy Benefit Analytics, Reporting & Employer Consulting (HLAEAKAK)
- akta.pro secondary industries
- PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL), Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
Keywords
Where RxAnte is headquartered
LocationHeadquarters
- HQ city
- Portland
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
RxAnte business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Subscription Analytics Services: Population-level reporting, forecasts, and member-level predictions delivered on a subscription basis to inform medication adherence and intervention strategies for chronic illness medications.
- Value-Based Pharmacy Services (Mosaic Pharmacy Service): High-touch, data-driven pharmacy care management services for medically complex and vulnerable Medicare populations. Delivered as a technology-enabled pharmacy care management subsidiary.
- Performance-Based Contracts: Value-based arrangements where RxAnte facilitates collection and analysis of real-world evidence to inform value-based contracts between health plans and pharmaceutical manufacturers.
- Clinical Intervention Programs: Targeted patient-engagement programs, provider engagement, and direct-to-member interventions as part of turnkey adherence improvement programs.
Distribution channels3 records
Marketing channels11 records
RxAnte product offering
Product offeringCore offering
RxAnte builds patented predictive analytics software (RxAnte Core Analytics/RxAnte Score, Value of Future Adherence) that uses pharmacy and medical claims data to forecast medication adherence and identify at-risk members. Its RxEffect workflow solution operationalizes these predictions for pharmacists, care managers, and providers, while the Mosaic Pharmacy Service subsidiary delivers in-home, value-based pharmacy care to medically complex Medicare beneficiaries. Customers are enterprise health plans, Medicaid plans, and value-based provider organizations.
Product overview
RxAnte is a health technology company offering a platform-plus-modules architecture for pharmacy care management. The core RxAnte Core Analytics / RxAnte Score platform provides patented predictive analytics for medication adherence risk assessment and member prioritization. RxEffect serves as the clinical workflow and adherence workflow solution for care managers and pharmacists. Mosaic Pharmacy Service is a technology-enabled subsidiary delivering high-touch pharmacy care for medically complex Medicare populations. The platform also includes specialized products like Value of Future Adherence (VFA) and Risk of Unsafe Use Score for opioid risk identification. The system combines advanced data science with practical clinical application to help health plans achieve measurable improvements in quality of care, total cost of care, and member experience.
Differentiator
Problem solved
Functional benefit
Brands
- Mosaic Pharmacy Service: A technology-enabled pharmacy care management subsidiary that provides high-touch, data-driven pharmacy care for medically complex and vulnerable populations, managing care for over 34 million lives across U.S. health plans as of 2026.
Products and services
- RxAnte Core Analytics / RxAnte Score Patented predictive analytics platform that uses pharmacy and medical claims data to assess risk of unsafe medication use, predict future medication adherence at the member level, and generate risk scores to prioritize outreach. Sold to enterprise health plans, Medicaid plans, and value-based providers.
- RxEffect Adherence Workflow Solution Clinical workflow and decision-support platform for pharmacists, care managers, and community-based providers that translates RxAnte's predictive analytics into configurable adherence workflows, weekly management reporting, and targeted patient-engagement program delivery. Sold to health plans and the providers serving their members.
- Mosaic Pharmacy Service Technology-enabled, value-based pharmacy care management service delivered by RxAnte's wholly-owned subsidiary to medically complex and vulnerable Medicare populations, providing high-touch, data-driven in-home pharmacy care to reduce hospitalizations and total cost of care. Sold directly to enterprise health plans.
Quantifiable outcome
- $406 PMPM savings; 32% reduction in inpatient stays
- +6 more outcomes
Companies that use RxAnte
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles3 records
RxAnte technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
RxAnte partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered significant, minor and core.
- Geisinger Health PlansignificantPartnership announced February 2019. RxAnte delivers population-level analytics and member-level decision support to inform Geisinger's pharmacy quality strategy, focusing on members' adherence to diabetes, hypertension, and high cholesterol medications.
- CoalfireminorCoalfire served as the HITRUST CSF Assessor conducting a thorough review of RxAnte's policies and practices during the HITRUST CSF certification process, focusing on oversight of the organization, vendor management programs, internal corporate governance, and risk management processes.
- EnvisionInsurancesignificantPartnership continued July 2016. RxAnte uses data from large patient populations to predict individual patient adherence and develops customized interventions and outreach programs for each member, improving health outcomes and controlling costs for EnvisionInsurance's Part D members.
- Horizon Healthcare Services, Inc.significantRenewed collaboration in May 2016. RxAnte provides advanced analytics solutions to predict future outcomes and manage prescription medication use for Horizon's Medicare Advantage population. Focus on triple-weighted Star Ratings medication adherence measures.
- UPMC Health PlancoreUPMC Health Plan has been a partner since 2016, collaborating on peer-reviewed outcomes studies demonstrating Mosaic's effectiveness in improving health outcomes and reducing medical costs. UPMC also established a Center for Value-Based Purchasing for Pharmaceuticals in partnership with RxAnte. Brent Burns, EVP of UPMC Enterprises, stated Primus partnership will help accelerate bringing RxAnte solutions to more patients.
- AvMedsignificantPartnership announced November 2015. RxAnte's advanced analytics platform delivered population-level reporting and member-level predictions to inform AvMed's adherence and intervention strategy for medications used to treat chronic illnesses for the Medicare Advantage Part D population.
- Pharmacy Quality Alliance (PQA)significantRxAnte collaborated with PQA, Aetna, and WellCare to devise new performance measures to address opioid misuse/abuse. PQA endorsed these new opioid quality measures, which unsafe opioid use leads to nearly 100,000 ER visits annually.
- WellCare Health PlanssignificantAgreement entered January 2014. RxAnte's advanced analytics platform used to identify existing Medicare members eligible for WellCare's Medication Therapy Management (MTM) services. WellCare has been providing MTM services since 2006 and working with RxAnte on medication quality measures since 2012.
- AetnasignificantInnovative program launched in 2013 to engage providers in improving medication adherence for patients predicted to be at high risk. Co-hosted webinar between Aetna VP of Star Ratings and RxAnte senior leadership on pay-for-performance programs and medication adherence.
Scale indicators14 records
Recent moves6 records
Expansion highlights6 records
RxAnte competitors and assessment
Company assessmentDirect peers
- AllazoHealth: AllazoHealth is an AI-driven medication adherence prediction platform serving health plans and PBMs. It is the closest functional peer to RxAnte, using predictive analytics on claims data to target adherence interventions for similar payer customers.
- AdhereHealth: AdhereHealth provides medication adherence analytics and pharmacy care management services to Medicare Advantage, Medicaid, and commercial health plans. It overlaps directly with RxAnte's core analytics + intervention model and shares the same payer customer base.
- OptimizeRx: OptimizeRx operates a digital therapeutics and adherence platform targeting prescribers and patients, with a network reaching the majority of US prescribers. It is comparable to RxAnte in addressing medication adherence through data-driven, point-of-care engagement with overlapping payer and pharma customers.
- mPulse Mobile: mPulse Mobile delivers conversational AI-driven patient engagement programs for medication adherence, condition management, and health plan quality measures. It serves many of the same MA and Medicaid plans as RxAnte, executing the patient-engagement layer that RxAnte's RxEffect orchestrates.
- Medisafe: Medisafe is a digital medication adherence platform combining a consumer app, predictive analytics, and payer integrations. It targets a similar problem space as RxAnte (medication non-adherence in chronic disease) but with more consumer-direct positioning, making it a partial-overlap peer.
- emocha Health: emocha Health provides a medication adherence platform with directly observed therapy and asynchronous video verification, increasingly used by health plans for MTM and Star Ratings programs. It overlaps with RxAnte's clinical workflow and MTM focus areas.
Emerging players
- Pack4U (Tabula Rasa HealthCare / CarelonRx): Pack4U delivers in-home and tech-enabled pharmacy services for complex patients, closely mirroring RxAnte's Mosaic Pharmacy Service value-based model. Both target medically complex Medicare populations with high-touch pharmacy care, though Pack4U is at an earlier commercial scale.
Broad incumbents
- DrFirst: DrFirst provides ePrescribing, medication management, and clinical messaging across a large healthcare provider network. While broader in scope than RxAnte, its medication history, benefit, and adherence tooling overlaps with RxEffect and serves some of the same payer-provider ecosystem.
- Surescripts: Surescripts operates the dominant US pharmacy electronic prescribing network and increasingly offers clinical and adherence-related intelligence to payers and providers. It is a broader infrastructure incumbent in the prescription data flow that RxAnte's analytics are built on.
- CVS Health (Caremark): CVS Caremark is one of the largest US PBMs with in-house adherence analytics, MTM programs, and value-based pharmacy initiatives. While not a direct SaaS competitor, it represents the vertically integrated incumbent that may build or buy capabilities competitive with RxAnte.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
RxAnte social profiles
Digital presenceRxAnte compliance and trust
Trust signalCompliance3 records
RxAnte financial estimates
Financial estimateRevenue estimate
Valuation estimate
RxAnte leadership team
Management profileNumber of profiles
Profiles6 records
RxAnte subsidiaries and ownership
Company hierarchySubsidiaries1 record
RxAnte funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RxAnte M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RxAnte
What does RxAnte do?
RxAnte builds patented predictive analytics software (RxAnte Core Analytics/RxAnte Score, Value of Future Adherence) that uses pharmacy and medical claims data to forecast medication adherence and identify at-risk members. Its RxEffect workflow solution operationalizes these predictions for pharmacists, care managers, and providers, while the Mosaic Pharmacy Service subsidiary delivers in-home, value-based pharmacy care to medically complex Medicare beneficiaries. Customers are enterprise health plans, Medicaid plans, and value-based provider organizations.
Is RxAnte a public or private company?
RxAnte is a private company. It is classified as private equity controlled and is currently operating.
When was RxAnte founded?
RxAnte was founded in 2011. It employs 51 to 100 people.
Where is RxAnte based?
RxAnte is headquartered in Portland, United States, in the North America region.
How does RxAnte make money?
Four revenue lines are on record. Subscription Analytics Services are the primary driver. The others are value-Based Pharmacy Services (Mosaic Pharmacy Service), performance-Based Contracts and clinical Intervention Programs.
Who are RxAnte's main competitors?
Direct peers on record are AllazoHealth, AdhereHealth, OptimizeRx, mPulse Mobile, Medisafe and emocha Health. Pack4U (Tabula Rasa HealthCare / CarelonRx) is listed as an emerging player. Broad incumbents are DrFirst, Surescripts and CVS Health (Caremark).
Does RxAnte have an API?
No public API is recorded for RxAnte.
What industry is RxAnte in?
RxAnte's product category is Pharmacy Care Management Analytics. Its primary akta.pro industry code is HLAEAKAK, Pharmacy Benefit Analytics, Reporting & Employer Consulting, with a secondary code of HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools). Its NAICS code is 5417 and its SIC code is 7372.